Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+20.6%
5Y CAGR+11.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+20.6%/yr
Annual compound
5Y CAGR
+11.3%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$34.69M+55.8%
2024$22.26M-27.2%
2023$30.56M+54.5%
2022$19.78M+99.1%
2021$9.94M-51.1%
2020$20.34M-